Skip to content
← Full study record

NCT02516241 · FLOW

Participant flow

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer · Source last updated 2026-07-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    MEDI4736 (Durvalumab) + Tremelimumab
    id
    FG000
    title
    Combination Therapy
  2. description
    MEDI4736 (Durvalumab)
    id
    FG001
    title
    Monotherapy
  3. description
    Standard of Care Chemotherapy Treatment
    id
    FG002
    title
    Standard of Care
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        255
      2. group Id
        FG001
        num Subjects
        262
      3. group Id
        FG002
        num Subjects
        270
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        12
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        84
      2. group Id
        FG001
        num Subjects
        76
      3. group Id
        FG002
        num Subjects
        59
      type
      participants ongoing at data cut-off
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        342
      2. group Id
        FG001
        num Subjects
        346
      3. group Id
        FG002
        num Subjects
        344
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        340
      2. group Id
        FG001
        num Subjects
        345
      3. group Id
        FG002
        num Subjects
        313
      type
      Received Treatment
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        342
      2. group Id
        FG001
        num Subjects
        346
      3. group Id
        FG002
        num Subjects
        344
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    MEDI4736 (Durvalumab) + Tremelimumab
    id
    FG000
    title
    Combination Therapy
  2. description
    MEDI4736 (Durvalumab)
    id
    FG001
    title
    Monotherapy
  3. description
    Standard of Care Chemotherapy Treatment
    id
    FG002
    title
    Standard of Care
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        255
      2. group Id
        FG001
        num Subjects
        262
      3. group Id
        FG002
        num Subjects
        270
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        3
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        12
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        84
      2. group Id
        FG001
        num Subjects
        76
      3. group Id
        FG002
        num Subjects
        59
      type
      participants ongoing at data cut-off
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        342
      2. group Id
        FG001
        num Subjects
        346
      3. group Id
        FG002
        num Subjects
        344
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        340
      2. group Id
        FG001
        num Subjects
        345
      3. group Id
        FG002
        num Subjects
        313
      type
      Received Treatment
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        342
      2. group Id
        FG001
        num Subjects
        346
      3. group Id
        FG002
        num Subjects
        344
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice